Standard immunoassay screens for benzodiazepines miss several important compounds, especially clonazepam and lorazepam metabolites. Confirmatory testing identifies specific benzodiazepines including alprazolam, diazepam, lorazepam, clonazepam, and their active metabolites, providing the accurate information needed for clinical and legal decisions.
This test is used following positive screens, for medico-legal documentation, treatment program compliance monitoring, and clinical assessment. Sample type is urine, often under chain-of-custody protocols.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment